Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological and computational evaluation of resveratrol inhibitors against Alzheimer's disease.
Koukoulitsa C, Villalonga-Barber C, Csonka R, Alexi X, Leonis G, Dellis D, Hamelink E, Belda O, Steele BR, Micha-Screttas M, Alexis MN, Papadopoulos MG, Mavromoustakos T. Koukoulitsa C, et al. Among authors: hamelink e. J Enzyme Inhib Med Chem. 2016;31(1):67-77. doi: 10.3109/14756366.2014.1003928. Epub 2015 Jul 6. J Enzyme Inhib Med Chem. 2016. PMID: 26147348
Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
Sund C, Belda O, Borkakoti N, Lindberg J, Derbyshire D, Vrang L, Hamelink E, Åhgren C, Woestenenk E, Wikström K, Eneroth A, Lindström E, Kalayanov G. Sund C, et al. Among authors: hamelink e. Bioorg Med Chem Lett. 2012 Nov 1;22(21):6721-7. doi: 10.1016/j.bmcl.2012.08.097. Epub 2012 Sep 5. Bioorg Med Chem Lett. 2012. PMID: 23010268
Design and synthesis of potent macrocyclic renin inhibitors.
Sund C, Belda O, Wiktelius D, Sahlberg C, Vrang L, Sedig S, Hamelink E, Henderson I, Agback T, Jansson K, Borkakoti N, Derbyshire D, Eneroth A, Samuelsson B. Sund C, et al. Among authors: hamelink e. Bioorg Med Chem Lett. 2011 Jan 1;21(1):358-62. doi: 10.1016/j.bmcl.2010.10.140. Epub 2010 Nov 5. Bioorg Med Chem Lett. 2011. PMID: 21112780
New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
Dahlgren A, Kvarnström I, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B. Dahlgren A, et al. Among authors: hamelink e. Bioorg Med Chem. 2003 Aug 5;11(16):3423-37. doi: 10.1016/s0968-0896(03)00312-2. Bioorg Med Chem. 2003. PMID: 12878137
New potent C2-symmetric malaria plasmepsin I and II inhibitors.
Oscarsson K, Oscarson S, Vrang L, Hamelink E, Hallberg A, Samuelsson B. Oscarsson K, et al. Among authors: hamelink e. Bioorg Med Chem. 2003 Apr 3;11(7):1235-46. doi: 10.1016/s0968-0896(02)00643-0. Bioorg Med Chem. 2003. PMID: 12628651
19 results